1. Berenblum, I. (1941). The cocarcinogenic action of croton resin. Cancer Res.1, 44–48.
2.
2. Hecker, E., and Bresch, H. (1965). Uber die wirkstoffe des crotonöls. Iii. Reindarstellung und characterisierung eines toxisch, entsündlich und cocarcinogen hochaktiven wirkstoffes. Zeits. Naturforsch.206, 216–226.
3.
3. Van Duuren, B.L., and Orris, L. (1965). The tumor-enhancing principles of Croton tiglium L. Cancer Res.25, 1871–1875.
4.
4. Roe, F.J.C. (1989). Animal tests for carcinogenesis: Relevance for man. J. Am. Coll. Toxicol.8, 1241–1246.
5.
5. Iversen, O.H., and Astrup, E.G. (1984). The paradigm of two-stage carcinogenesis: a critical attitude. Cancer Invest.2, 51–60.
6.
6. Iversen, O.H. (1988). Initiation, promotion: critical remarks on the two-stage theory. In: Iversen, O.H. (ed.). Theories of Carcinogenesis. Washington, DC: Hemisphere Publishing Company, pp. 119–126.
7.
7. Van Duuren, B.L. (1969). Tumor-promoting agents in two-stage carcinogenesis. In: Homburger, F., (ed.). Progress in Experimental Tumor Research. Basel: S. Karger, pp. 31–68.
8.
8. Van Duuren, B.L., Sivak, A., Katz, C., Seidman, I., and Melchionne, S. (1975). The Effect of aging and interval between primary and secondary treatment in two-stage carcinogenesis on mouse skin. Cancer Res.35, 502–505.
9.
9. Van Duuren, B.L., Sivak, A., Segal, A., Seidman, I., and Katz, C. (1973). Dose-response studies with a pure tumor-promoting agent, phorbol myristate acetate. Cancer Res.33, 2166–2172.
10.
10. Van Duuren, B.L., Langseth, L., Sivak, A., and Orris, L. (1966). The tumor-enhancing principles of Croton tiglium L. Ii. A comparative study. Cancer Res.26, 1729–1733.
